Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Bolt Biotherapeutics, Inc. (BOLT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-KS-1/A
Revenues  1.30.226.09.4
            Revenue growth  445.5%-99.1%176.0% 
Cost of goods sold  0.00.031.211.6
Gross profit  1.30.2-5.2-2.2
            Gross margin  100.0%100.0%-19.9%-23.5%
Selling, general and administrative   [+]94.049.45.22.2
Other operating expenses  11.623.120.67.2
EBITDA   [+]-103.2-71.7-30.6-11.3
            EBITDA margin  -8190.6%-31022.9%-117.8%-120.2%
Depreciation and amortization  1.20.60.30.3
EBIT   [+]-104.4-72.3-31.0-11.6
            EBIT margin  -8285.2%-31287.4%-119.1%-123.5%
Interest income  0.30.2  
Other income (expense), net  5.511.331.00.0
Pre-tax income  -98.6-60.70.0-11.6
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0% 0.0%
Net income  -98.6-60.70.0-11.6
            Net margin  -7824.7%-26289.2%0.0%-123.0%
   
Basic EPS   [+]($2.97)($30.53)$0.00($7.02)
Diluted EPS   [+]($2.97)($30.53)$0.00($7.02)
   
Shares outstanding (basic)   [+]33.22.01,993.51.7
Shares outstanding (diluted)   [+]33.22.01,993.51.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy